牙科手术对遗传性血管发作的影响:一项探索性观察性研究
Oral health & preventive dentistry
|March 14, 2025
概括
牙科手术经常引发遗传性血管 (HAE) 发作. 诊断改善了治疗,但恐惧的攻击和专业拒绝显著影响HAE患者的牙科护理机会.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 牙科医学 牙科医学
背景情况:
- 遗传性血管 (HAE) 是一种罕见的遗传性疾病,其特点是经常出现的发作.
- 牙科手术可能是HAE发作的潜在触发因素,影响患者管理和口腔健康.
- 了解牙科干预和HAE发作之间的联系对于改善患者护理至关重要.
研究的目的:
- 评估与牙科手术相关的HAE发作的频率.
- 为了确定患者在HAE诊断后是否接受更合适的治疗后牙科攻击.
- 调查感知风险对HAE患者寻求和提供牙科护理的影响.
主要方法:
- 一项使用罗马尼亚遗传性血管水登记的观察性研究.
- 数据通过对同意的成年患者进行结构化的20个问题的电话调查收集.
- 评估与牙科手术和治疗模式相关的HAE发作频率.
主要成果:
- 超过一半的HAE患者在诊断前 (47.6%) 和诊断后 (51.9%) 经历了牙科手术后的胀.
- 诊断前的治疗往往涉及葡萄皮质类药物/抗胰岛素;诊断后,使用适当的HAE特异性治疗 (Icatibant,C1-INH) (85.3%).
- 对攻击或拒绝的恐惧导致55.3%的人避免牙科护理,24.7%的人报告被专业人员拒绝照顾.
结论:
- 牙科手术是HAE患者胀的常见触发因素.
- 准确的HAE诊断有助于从不适当的症状治疗转向有效的HAE特定疗法.
- 由于HAE问题,患者报告的大量避免牙科护理和专业拒绝突出了口腔健康维护的障碍.
相关概念视频
01:12Local Anesthetics: Adverse Effects
385
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
385
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
02:06Allergic Reactions
27.2K
Overview
27.2K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
466
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
466
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
121
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
121
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
439
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
439